1. Home
  2. CMMB vs TAOP Comparison

CMMB vs TAOP Comparison

Compare CMMB & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$2.00

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

TAOP

Taoping Inc.

N/A

Current Price

$1.38

Market Cap

12.8M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CMMB
TAOP
Founded
2004
1993
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
12.8M
IPO Year
2023
2012

Fundamental Metrics

Financial Performance
Metric
CMMB
TAOP
Price
$2.00
$1.38
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
41.4K
5.8K
Earning Date
05-21-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
101.67
N/A
EPS
0.04
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$46.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$1.18
52 Week High
$3.86
$8.78

Technical Indicators

Market Signals
Indicator
CMMB
TAOP
Relative Strength Index (RSI) 66.56 57.56
Support Level $1.44 $1.20
Resistance Level $2.24 $1.59
Average True Range (ATR) 0.15 0.06
MACD 0.02 0.01
Stochastic Oscillator 83.50 77.74

Price Performance

Historical Comparison
CMMB
TAOP

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-based technology solutions, smart city IoT platforms, digital advertising delivery systems, and internet-based information distribution systems in China. The company has three reportable segments. The Cloud-based Technology segment includes cloud-based products, high-end data storage servers, advertising services, and customized software solutions for private sector customers. The Traditional Information Technology segment includes project-based technology products and services sold to the public sector, including Geographic Information Systems, Digital Public Security Technology, and Digital Hospital Information Systems. The Smart Elevator segment provides elevator sales, installation, maintenance, renovation, and cloud-based maintenance services.

Share on Social Networks: